Venous thrombosis prophylaxis by inflammatory inhibition without anticoagulation therapy

Journal of Vascular Surgery

Volumn 31, Issue 2, 2000, Pages 309-324

  Wakefield, Thomas W ^a,c   Strieter, Robert M ^a   Schaub, Robert ^b   Myers, Daniel D ^a   Prince, Martin R ^a   Wrobleski, Shirley K ^a   Londy, Frank J ^a   Kadell, Amy M ^a   Brown, Sandra L ^a   Henke, Peter K ^a   Greenfield, Lazar J ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b PFIZER INC   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GADOLINIUM; P SELECTIN GLYCOPROTEIN LIGAND 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOTTING TIME; CONTROLLED STUDY; HEMODYNAMICS; INFERIOR CAVA VEIN OBSTRUCTION; MORPHOMETRICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; THROMBOCYTE COUNT; THROMBOSIS PREVENTION; THROMBUS; VEIN THROMBOSIS;

EID: 12944283206     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0741-5214(00)90162-9     Document Type: Article

References (30)

1. Wakefield TW, Strieter RM, Wilke CA, Kadell AM, Wrobleski SK, Burdick MD, et al. Venous thrombosis-associated inflammation and attenuation with neutralizing antibodies to cytokines and adhesion molecules. Arterioscler Thromb Vasc Biol 1995;15:258-68.
2. Wakefield TW, Greenfield LJ, Rolfe MW, DeLucia A III, Stricter RM, Abrams GD, et al. Inflammatory and procoagulant mediator interactions in an experimental baboon model of venous thrombosis. Thromb Haemost 1993;69:164-72.
3. Downing LJ, Wakefield TW, Stricter RM, Prince MR, Londy FJ, Fowlkes JB, et al. Anti-P-selectin antibody decreases inflammation and thrombus formation in venous thrombosis. J Vasc Surg 1997;25:816-28.
4. Downing LJ, Stricter RM, Kadell AM, Wilke CA, Austin JC, Hare BD, et al. Interleukin-10 regulates thrombus-induced vein wall inflammation and thrombosis. J Immunol 1998; 161:1471-6.
5. McEver RP, Cummings RD. Role of PSGL-1 binding to selectins in leukocyte recruitment. J Clin Invest 1997;100: 485-92.
6. Prince MR. Gadolinium-enhanced MR aortography. Radiology 1994;191:155-64.
7. Drozdz J, Schon F, Nesser HJ, Erbel R. Tissue doppler echocardiography - new promising method in cardiovascular diagnosis. Essen, 09.08.94.
8. Theoret JF, Kumar A, Latour J-G, Merhi Y. Mechanisms of platelet binding to neutrophils in contact with damaged arterial surfaces under flow conditions. Circulation 1998;98:I-241,1251.
9. Hayward R, Campbell B, Shin YK, Scalia R, Lefer AM. Recombinant soluble P-selectin glycoprotein ligand-1 protects against myocardial ischemic reperfusion injury in cats. Cardiovasc Res 1999;41:65-76.
10. Scalia R Hayward R, Armstead VE, Minchenko AG, Lefer AM. Effect of recombinant soluble P-selectin glycoprotein ligand-1 on leukocyte-endothelium interaction in vivo. Role in rat traumatic shock. Circulation Res 1999;84:93-102.
11. Dulkanchainun TS, Goss JA, Imagawa DK, Shaw GD, Anselmo DM, Kaldas F, et al. Reduction of hepatic ischemia/reperfusion injury by a soluble P-selectin glycoprotein ligand-1. Ann Surg 1998;227:832-40.
12. Takada M, Nadeau KC, Shaw GD, Marquette KA, Tilney NL. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand. J Clin Invest 1997;99:2682-90.
13. Lefer AM, Campbell B, Scalia R, Lefer DJ. Synergism between platelets and neutrophils in provoking cardiac dysfunction after ischemia and reperfusion: role of selectins. Circulation 1998;98:1322-8.
14. Guyer DA, Moore KL, Lynam EB, Schammel CM, Rogelj S, McEver RP, et al. P-selectin glycoprotein ligand-1 (PSGL-1) is a ligand for L-selectin in neutrophil aggregation. Blood 1996;88:2415-21.
15. Stricter RM, Koch AE, Antony VB, Fick RB, Standiford TJ, Kunkel SL. The immunopathology of chemotactic cytokines: the role of interleukin-8 and monocyte chemoattractant protein-1. J Lab Clin Med 1994;123:183-97.
16. Kumar A, Villani MP, Patel UK, Keith JC, Schaub RG. Recombinant soluble form of PSGL-1 accelerates thrombolysis and prevents reocclusion in a porcine model. Circulation 1999;99:1363-9.
17. Toombs CF, DeGraaf GL, Martin JP, Geng JG, Anderson DC, Shebuski RJ. Pretreatment with a blocking monoclonal antibody to P-selectin accelerates pharmacological thrombolysis in a primate model of arterial thrombosis. J Pharmacol Exp Ther 1995;275:941-9.
18. Palabrica T, Lobb R, Furie BC, Aronovitz M, Benjamin C, Hsu YM, et al. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature 1992;359:848-51.
19. Celi A, Pellegrini G, Lorenzet R, De Blasi A, Ready N, Furie BC, et al. P-selectin induces the expression of tissue factor on monocytes. Proc Natl Acad Sci U S A 1994;91:8767-71.
20. Stricter RM, Kunkel SL. Acute lung injury: the role of cytokines in the elicitation of neutrophils. J Investig Med 1994;42:640-51.
21. Yeo EL, Sheppard JA, Fuerstein IA. Role of P-selectin and leukocyte activation in polymorphonuclear cell adhesion to surface adherent activated platelets under physiologic shear conditions (an injury vessel wall model). Blood 1994;83:2498-507.
22. Weyrich AS, McIntyre TM, McEver RP, Prescott SM, Zimmerman GA. Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-alpha secretion. Signal integration and NF-kappa B translocation. J Clin Invest 1995;95:2297-303.
23. Murohara T, Parkinson SJ, Waldman SA, Lefer AM. Inhibition of nitric oxide biosynthesis promotes P-selectin expression in platelets. Role of protein kinase C. Arterioscler Thromb Vasc Biol 1995;15:2068-75.
24. Celi A, Pellegrini G, Lorenzet R, De Blasi A, Ready N, Furie BC, et al. P-selectin induces the expression of tissue factor on monocytes. Proc Natl Acad Sci U S A 1994;91:8767-71.
25. Chen CC, Manning AA. Transcriptional regulation of endothelial cell adhesion molecules: a dominant role for NF-kappa B. Agents Actions 1995;47:135S-41S.
26. Weiser MR, Gibbs SA, Valeri CR, Shepro D, Hechtman HB. Anti-selectin therapy modifies skeletal muscle ischemia and reperfusion injury. Shock 1996;5:402-7.
27. Yadav SS, Howell DN, Steeber DA, Harland RC, Tedder TF, Clavien P-E. P-selectin mediates reperfusion injury through neutrophil and platelet sequestration in the warm ischemic mouse liver. Hepatology 1999;29:1494-502.
28. Jaeschke H. Is anti-P-selectin therapy effective in hepatic ischemia-reperfusion injury because it inhibits neutrophil recruitment? Shock 1999;12:233-4.
29. Zhang H, Schaub RG, Khor SP, Keith JC Jr, Kumar A. Anti-thrombotic effect of a recombinant soluble P-selectin glycoprotein ligand-1 chimera in a rat model of thrombosis [abstract]. Circulation 1999;100(Suppl 1):I471.
30. Eppihimer MJ, Schaub RG. Effect of recombinant PSGL-I (rPSGL-Ig) on vascular injury and thrombosis following venous stasis [abstract]. Circulation 1999;100(Suppl 1)I812.